GlassScriptPhysician profile
Nathan G Berger
NPI 1639148851
$1,594.71
in general payments reported to CMS, 2019-2025
18 companies · $353 in 2025
The $353 reported for 2025 was more than what 81% of Reproductive Endocrinology providers received nationally (typical 2025 total: $140).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $415 · 2020: $111 · 2021: $117 · 2022: $270 · 2023: $230 · 2024: $98.98 · 2025: $353.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $596 · Education: $84.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $596.40 |
| Education | $84.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $356.02 | 2023-2025 | Veozah |
| Abbvie INC. | $176.62 | 2019-2021 | |
| Minerva Surgical, INC | $164.76 | 2022 | |
| Sage Therapeutics, LLC | $159.39 | 2025 | Zurzuvae |
| Lupin INC. | $123.08 | 2019 | |
| Hologic Sales and Service, LLC | $105.51 | 2022 | |
| Coopersurgical, INC. | $92.77 | 2019 | |
| Renovia INC | $75.47 | 2019 | |
| Supernus Pharmaceuticals, INC. | $66.11 | 2025 | Qelbree |
| Olympus America INC. | $59.63 | 2020 | |
| Mayne Pharma Commercial LLC | $54.44 | 2023-2025 | |
| Organon LLC | $45.43 | 2024-2025 | Nexplanon |
| Mylan Pharmaceuticals INC. | $26.38 | 2021 | |
| Axonics, INC. | $22.45 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $20.55 | 2020 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $16.62 | 2021 | |
| Pfizer INC. | $14.91 | 2019 | |
| Laborie Medical Technologies Corp. | $14.57 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nathan Berger listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.